Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Reexamination Certificate
2007-02-21
2010-06-15
Li, Q. Janice (Department: 1633)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
C424S093210, C435S320100
Reexamination Certificate
active
07736641
ABSTRACT:
The present invention relates to a method for treating or preventing Parkinson's disease in a patient, the method comprising administering to the patient a therapeutically effective population of neuronal cells transformed with a nucleic acid molecule encoding SRY, wherein the transformed cells express SRY.
REFERENCES:
patent: 5175103 (1992-12-01), Lee et al.
patent: 7011827 (2006-03-01), Lee et al.
Su et al. Am J Hum Genet 1993;52:24-38.
Hacker et al., “Expression of Sry, the mouse sex determining gene” Development, 121:1603-1614 (1995).
Hargrave et al., “Expression of the Sox11 Gene in Mouse Embryos Suggests Roles in Neuronal Maturation and Epithelio- Mesenchymal Induction” Developmental Dynamics, 210:79-86 (1997).
Harley et al., “DNA Binding Activity Recombinant SRY from Normal Males and XY Females” Science, 255 (5043):453-456 (1992).
Iacovitti et al., “Expression of tyrosine hydroxylase in newly differentiated neurons from a human cell line (hNT)” NeuroReport, 8:1471-1474 (1997).
Ivanova et al., “Estrogen Regulates Tyrosine Hydroxylase Expression in the Neonate Mouse Midbrain” J. Neurobiol., 54:638-647 (2003).
Jeske et al., “Expression of a linear Sry transcript in the mouse genital ridge” Nature Genetics, 10:480-482 (1995).
King et al., “The SRY high-mobility-group box recognizes DNA by partial intercalation in the minor groove: A topological mechanism of sequence specificity” Proc. Natl. Acad. Sci. USA, 90:11990-11994 (1993).
Koopman et al., “Expression of a candidate sex-determining gene during mouse testis differentiation” Nature, 348:450-452 (1990).
Koopman et al., “Male development of chromosomally female mice transgenic for Sry” Nature, 351:117-121 (1991).
Kumer et al., “Intricate Regulation of Tyrosine Hydroxylase Activity and Gene Expression” Journal of Neurochemistry, 67(2):443-462 (1996).
Lahr et al., “Transcription of the Y chromosomal gene, Sry, in adult mouse brain” Molecular Brain Research, 33:179-182 (1995).
Landgraf, R., “Antisense targeting in behavioral neuroendocrinology” Journal of Endocrinology, 151:333-340 (1996).
Laudet et al., “Ancestry and diversity of the HMG box superfamily” Nucleic Acids Research, 21(10):2493-2501 (1993).
Lee et al., “Differentiation of NTERA-2 Clonal Human Embryonal Carcinoma Cells into Neurons Involves the Induction of All Three Neurofilament Proteins” The Journal of Neuroscience, 6(2):514-521 (1996).
Leranth et al., “Estrogen Is Essential for Maintaining Nigrostriatal Dopamine Neurons in Primates: Implications for Parkinson's Disease and Memory” The Journal of Neuroscience, 20(23):8604-8609 (2000).
Lindvall et al., “Transplantation in Parkinson's Disease: Two Cases of Adrenal Medullary Grafts to the Putamen” Ann. Neurol., 22:457-468 (1987).
Madrazo et al., “Open Microsurgical Autograft of Adrenal Medulla to the Right Caudate Nucleus in Two Patient With Intractable Parkinson's Disease” The New England Journal of Medicine, 316(14):831-834 (1987).
Maharjan et al., “Transcriptional regulation of tyrosine hydroxylase by estrogen: opposite effects with estrogen receptors a and b and interactions with cyclic AMP” Journal of Neurochemistry, 93:1502-1514 (2005).
Malbon, Craig C., “Frizzleds: New Members of the Superfamily of G-Protein-Coupled Receptors” Bioscience, 9:1048-1058 (2004).
Abraham et al., “Increased PKA and PKC Activities Accompany Neuronal Differentiation of NT2/D1 Cells” Journal of Neuroscience Research, 28:29-30 (1991).
Andrews et al., “Pluripotent Embryonal Carcinoma Clones Derived from the Human Teratocarcinoma Cell Line Tera-2” Laboratory Investigation, 50(2):147-162 (1984).
Andrews, Peter W., “Retinoic Acid Induces Neuronal Differentiation of a Cloned Human Embryonal Carcinoma Cell Line in Vitro” Developmental Biology, 103:285-298 (1984).
Andrews et al., “The expression of MHC antigens by human teratocarcinoma derived cell lines” Tissue Antigen, 17:493-500 (1981).
Bani-Yaghoub et al., “Human NT2/D1 cells differentiate into functional astrocytes” Development Neuroscience, 10 (18)3843-3846 (1999).
Becker, Jill B., “Gender Differences in Dopaminergic Function in Striatum and Nucleus Accumbens” Pharmacology Biochemistry and Behavior, 64(4):803-812 (1999).
Carruth et al., “Sex chromosome genes directly affect brain sexual differentiation” Nature Neuroscience, 5 (10):933-934 (2002).
Castelo-Branco et al., “GSK-3B inhibition/B-catenin stabilization in ventral midbrain precursors increases differentiation into dopamine neurons” Journal of Cell Science, 117:5731-5737 (2004).
Castillo et al., “Dopamine Biosynthesis Is Selectively Abolished in Substantia Nigra/Ventral Tegmental Area but Not in Hypothalmic Neurons in Mice with Targeted Disruption of the Nurr1 Gene” Molecular and Cellular Neuroscience, 11:36-46 (1998).
Castner et al., “Sex differences in striatal dopamine: in vivo microdialysis and behavioral studies” Brain Research, 610:127-134 (1993).
Cheung et al., “Identification of Candidate Genes Induced by Retinoic Acid in Embryonal Carcinoma Cells” Journal of Neurology, 68(5):1882-1888 (1997).
Dewing et al., “Direct Regulation of Adult Brain Function by the Male Specific Factor SRY” Current Biology, 16:415-420 (2006).
Dluzen et al., “Estrogen As a Modulator of Striatal Dopaminergic Neurotoxicity” Advantage in Neurodegenerative Disorders vol. 1: Parkinson's Disease, Edited by Joe Marwah and Herman Teitelbaum, Chapter 5, pp. 102-146, 1996.
Fernandez-Ruiz, et al., “Nigrostriatal and mesolimbic dopaminergic activities were modified throughout the ovarian cycle of female rats” J. Neural. Transm., 85:223-229 (1991).
Ferrari et al., “SRY, like HMG1, recognizes sharp angles in DNA” The EMBO Journal, 11(12):4497-4506 (1992).
Fleming et al., “Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenone” Experimental Neurology, 187:418-429 (2004).
Gao et al., “Retinoic Acid Induction of Calcium Channel Expression in Human NT2N Neurons” Biochemical and Biophysical Research Communications, 247:407-413 (1998).
Gonzalez-Hernandez, et al., “Compartmental Organization and Chemical Profile of Dopaminergic and GABAergic Neurons in the Substantia Nigra of the Rat” The Journal of Comparative Neurology, 421:107-135 (2000).
Gundersen et al., “The new stereological tools: Disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis.” APMIS, 96:857-881 (1998).
Mayer et al., “The Y-chromosomal genes SRY and ZFY are transcribed in adult human brain” Neurogenetics, 1:281-288 (1998).
Mayer et al., “Developmental profile of Sry transcripts in mouse brain” Neurogenetics, 3:25-30 (2000).
Misiuta et al., “The transcription factor Nurr1 in human NT2 cells and hNT neurons” Developmental Brain Research, 145:107-115 (2003).
Moon et al., “WNT and B-Catenin Signalling: Diseases and Therapies” Nature, 5:689-699 (2004).
Nasrin et al., “DNA-binding properties of the product of the testis-determining gene and a related protein” Nature, 354:317-320 (1991).
Nusse, Roel, “Wnts and Hedgehogs: lipid-modified proteins and similarities in signaling mechanisms at the cell surface” Development, 130:5297-5305 (2003).
Olanow et al., “Etiology and Pathogenesis of Parkinson's Disease” Ann. Rev. Neurosci., 22:123-44 (1999).
Pevny et al., “Sox genes find their feet” Current Opinion in Genetics & Development, 7:338-344 (1997).
Pleasure et al., “Pure, Postmitotic, Polarized Human Neurons Derived from NTera 2 Cells Provid
Harley Vincent Russel
Vilain Eric J. N.
Bozicevic Karl
Bozicevic Field & Francis LLP
Li Q. Janice
Prince Henry's Institute of Medical Research
LandOfFree
Role for SRY in Parkinson's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Role for SRY in Parkinson's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Role for SRY in Parkinson's disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4242851